These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17326239

  • 1. Therapeutic vaccine for lymphoma.
    Lee ST, Neelapu SS, Kwak LW.
    Yonsei Med J; 2007 Feb 28; 48(1):1-10. PubMed ID: 17326239
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy for lymphomas.
    Timmerman JM.
    Int J Hematol; 2003 Jun 28; 77(5):444-55. PubMed ID: 12841382
    [Abstract] [Full Text] [Related]

  • 3. Idiotype vaccine strategies for treatment of follicular lymphoma.
    Mahaseth H, Brody JD, Sinha R, Shenoy PJ, Flowers CR.
    Future Oncol; 2011 Jan 28; 7(1):111-22. PubMed ID: 21174542
    [Abstract] [Full Text] [Related]

  • 4. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
    Hurvitz SA, Timmerman JM.
    Curr Opin Oncol; 2005 Sep 28; 17(5):432-40. PubMed ID: 16093791
    [Abstract] [Full Text] [Related]

  • 5. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May 28; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 6. Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma.
    Reinis M.
    Curr Opin Mol Ther; 2007 Jun 28; 9(3):291-8. PubMed ID: 17608028
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 28; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 8. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 28; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 9. Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.
    Koumarianou A, Kountourakis P, Economopoulos T.
    J Steroid Biochem Mol Biol; 2008 Apr 28; 109(3-5):230-2. PubMed ID: 18406604
    [Abstract] [Full Text] [Related]

  • 10. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I, Qin H, Kwak LW.
    Best Pract Res Clin Haematol; 2011 Jun 28; 24(2):295-304. PubMed ID: 21658625
    [Abstract] [Full Text] [Related]

  • 11. BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
    Flowers CR.
    Expert Rev Vaccines; 2007 Jun 28; 6(3):307-17. PubMed ID: 17542746
    [Abstract] [Full Text] [Related]

  • 12. [Past, present and future of anti-idiotype vaccination].
    Rodríguez Calvillo M, Inogés S, López Díaz de Cerio A, Zabalegui N, Panizo C, Hernández M, Pérez Calvo J, Prósper F, Melero I, Sánchez-Ibarrola A, Rocha E, Bendandi M.
    Rev Med Univ Navarra; 2004 Jun 28; 48(3):14-23. PubMed ID: 15622921
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H.
    Cancer Res; 2006 Apr 15; 66(8):4496-502. PubMed ID: 16618777
    [Abstract] [Full Text] [Related]

  • 15. Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial.
    Thomas SK, Kwak LW.
    Semin Oncol; 2012 Jun 15; 39(3):253-62. PubMed ID: 22595048
    [Abstract] [Full Text] [Related]

  • 16. Translational development of active immunotherapy for hematologic malignancies.
    Kwak LW.
    Semin Oncol; 2003 Jun 15; 30(3 Suppl 8):17-22. PubMed ID: 12881808
    [Abstract] [Full Text] [Related]

  • 17. Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update.
    Marron TU, Ronner L, Martin PE, Flowers CR, Brody JD.
    Immunotherapy; 2016 Nov 15; 8(11):1335-1346. PubMed ID: 27993085
    [Abstract] [Full Text] [Related]

  • 18. The role of idiotype vaccines in the treatment of human B-cell malignancies.
    Bendandi M.
    Expert Rev Vaccines; 2004 Apr 15; 3(2):163-70. PubMed ID: 15056042
    [Abstract] [Full Text] [Related]

  • 19. Idiotype vaccination for lymphoma: moving towards optimisation.
    Houot R, Levy R.
    Leuk Lymphoma; 2009 Jan 15; 50(1):1-2. PubMed ID: 19172492
    [No Abstract] [Full Text] [Related]

  • 20. Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
    Park HJ, Neelapu SS.
    Br J Haematol; 2008 Jun 15; 142(2):179-91. PubMed ID: 18422783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.